$1亿结算

3 月 7, 2016

这项和解是代表使用节育装置 NuvaRing® 的受伤妇女达成的。该案件是由消费者提起的,他们声称制造商未能充分警告消费者使用避孕药具可能导致血栓和其他伤害的风险增加,即使制造商意识到所涉及的风险。新泽西州的一家联邦法院早些时候提出了一个问题,即在被发现伤害其使用者后,这种节育装置可能会引起血栓。植入荷尔蒙的硅环被放置在阴道内,通过释放荷尔蒙来避免怀孕。据称该设备和药物混合物已导致使用者受伤和死亡。该诉讼始于 2008 年,原告律师是 Paul Napoli 的合伙人 Hunter J. Shkolnik,消费者表示该产品的制造商没有令人满意地提供有关血栓严重危险的警告,但制造商明白危险是真实存在的。  

类别: 医药诉讼

Everyday Appliances & Gadgets, Unexpected Risks: How to Protect Your Family

Hidden Dangers in Everyday Consumer Products We rely on a wide range of consumer products—appliances, gadgets, and household tools—to make daily life easier. However, many people are unaware...

阅读文章
Andexanet Alfa (Andexxa) Withdrawn from U.S. Market: What Patients Need to Know

by Christopher R. LoPalo, Partner AstraZeneca has withdrawn Andexxa (andexanet alfa) from the United States market effective December 22, 2025. Patients who experienced adverse health outcomes, complications, or...

阅读文章
PFAS in Biosolids: 2025 Statehouses Take the Lead

For PFAS in biosolids, 2025 was the year statehouses stepped decisively into the vacuum. While federal policy is evolving, state and local governments are rapidly redrawing the rules...

阅读文章
联系我们:
获得免费案例评估 律师推荐

我们的位置

联系我们 亲自预约